Baseline Characteristics and Outcomes for the 4F Pilot for Persons Aging with HIV
Julie Womack, Chloe Johnson, Evelyn Hsieh, Richard Marottoli, Wynnett Stewart, Michael Virata, Lydia Aoun-Barakat

TL;DR
This study examines baseline characteristics and outcomes of older adults with HIV to address aging-related health risks like polypharmacy and falls.
Contribution
The study introduces a pilot program training clinicians to assess and manage aging-related conditions in older HIV patients.
Findings
25% of patients experienced hyperpolypharmacy (15+ medications), and 66% were prescribed potentially inappropriate medications.
27% of women and 24% of men were at high risk for a serious fall within 6 months.
Only 18% of clinicians had assessed their patients' fracture risk.
Abstract
More than half of people living with HIV in the US are 50+ years of age. HIV clinicians must be comfortable assessing for and managing conditions associated with aging. We trained 11 clinicians at an academic HIV ambulatory care center to assess and prevent the 4F’s (polypharmacy, fragility fractures, falls) among their patients 50+ years old. We share baseline patient data and results from the HIV clinicians’ knowledge, attitudes, and practices baseline assessment. 125 patients were enrolled. Mean age was 63±6 years, 49% were women, 48% identified as Black. 30% were current smokers, and 30% reported ongoing marijuana use. The mean number of medications prescribed was 10±5. However, 25% experienced hyperpolypharmacy (taking 15+ medications), and 66% were prescribed potentially inappropriate medications (PIMs). Mean FRAX scores indicated low 10-year risk for fragility fractures (major…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV-related health complications and treatments · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions
